Trial phase Recruitment Randomisation/birth Discharge 7 days post randomisation 3 months 6 months 9 months 12 months End Part 1 18 months 24 months 30 months 36 months 42 months 48 months 54 months 60 months End Part 2
Year data collected 2013-2016 2013-2016 2013-2016 2013-2016 2013-2016 2014-2017 2014-2017 2014-2018 2015-2018 2015-2018 2016-2019 2016-2019 2017-2020 2017-2020 2018-2021 2018-2021
Medications
(eczema, wheezing)
P:BIS P:BIS P:BIS P:BIS P:BIS P:BIS P:BIS P:BIS P:BIS P:BIS P:BIS P:BIS
Supplements
(vitamin D)
M P:SDV P:SDV P:SDV P:SDV P:SDV P:SDV P:SDV P:SDV P:SDV P:SDV P:SDV P:SDV P:SDV
Medication/supplement use during pregnancy
(antibiotics, probiotics, folic acid,
pregnancy multivitamin, vitamin D)
M BM
P:SDV BM
M BM
P:SDV BM
M BM
Probiotics P:SDV BM P:SDV BM C
Epipen/Anapen prescription/use P:HN BM BF Si 1
P:BIS BM BF Si 1
P:HN P:HN P:HN P:HN P:HN P:HN P:HN P:HN P:HN P:HN P:HN P:HN

Featured measurements

BIS: Barwon Infant Study derived
SDV: Study Devised Variable
HN: HealthNuts Study derived

Notes

1 Full or half siblings only, not step-siblings

Legend

A = Administration report abstraction
C = Index child report (reporting on others)
L = Linkage (to other databases)
M = Medical records data abstraction
O = Observation/direct assessment
N = Nurse report
P = Parent/primary caregiver report
Pe = Peer report
S = Self report
T = Teacher report
X = Undefined
X BF = Pertaining to biological father
X BM = Pertaining to biological mother
C = Pertaining to index child
X F = Pertaining to father
X Fam = Pertaining to family
X G = Pertaining to grandparent(s)
X M = Pertaining to mother
X P = Pertaining to parent(s)
X Pa = Pertaining to partner
X Pe = Pertaining to peers
X Pr = Pertaining to primary caregiver
X Si = Pertaining to sibling(s)